Colistin Resistance among Enterobacteriaceae Isolated from Clinical Samples in Gaza Strip

Mohammad Qadi1, Safaa Alhato2, Rasha Khayyat1

  • 1Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, An-Najah National University, P.O.Box. 7, Nablus, Palestine, State of Palestine.

Insights

Drug-resistant bacterial infections are a major threat. This study found high colistin resistance (41%) and multidrug resistance (89%) in Gaza Strip clinical isolates, complicating treatment options.

Area of Science:

  • Clinical microbiology and infectious diseases.
  • Antimicrobial resistance surveillance.
  • Public health and global health security.

Background:

  • Bacterial infections, particularly those caused by multidrug-resistant (MDR) strains, pose a significant global health challenge.
  • Colistin is a critical last-line antibiotic for treating infections caused by MDR Gram-negative bacteria (GNB).
  • There is a concerning rise in colistin-resistant infections, necessitating urgent investigation.

Purpose of the Study:

  • To determine the prevalence of colistin resistance among clinical Gram-negative bacteria (GNB) isolated from hospitals in the Gaza Strip.
  • To assess the antimicrobial susceptibility patterns of these clinical isolates.
  • To evaluate the implications of resistance for treatment options.

Main Methods:

  • One hundred clinical Enterobacteriaceae isolates were collected from Gaza Strip hospitals over six months.
  • Standard microbiological procedures were used for bacterial identification.
  • Antimicrobial susceptibility testing was performed using the disk diffusion method, with colistin Minimum Inhibitory Concentration (MIC) determined.

Main Results:

  • High resistance rates were observed for trimethoprim (85%) and tetracycline (83%). Amikacin showed the highest efficacy (74%).
  • Overall colistin resistance was 41%, with highest resistance in Proteus spp. (63.2%) and Serratia spp. (57.1%).
  • Multidrug resistance (MDR) was prevalent, affecting 89% of isolates. Only 39% of meropenem-resistant and 45.8% of imipenem-resistant Enterobacteriaceae were susceptible to colistin.

Conclusions:

  • The study reveals a high prevalence of colistin resistance and MDR among clinical Enterobacteriaceae in the Gaza Strip.
  • These resistance patterns severely limit available treatment options for bacterial infections in the region.
  • Immediate actions are crucial for antimicrobial stewardship, focusing on monitoring and controlling the use of antimicrobials, especially colistin.